Study identifier:SD-039-0664
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Safety of a combination of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) in steroid-using asthmatic adults.
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: - 
Endpoint Classification: - 
Intervention Model: - 
Masking: - 
Primary Purpose: - 
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
| Arms | Assigned Interventions | 
|---|